Conclusion and Implications
This work highlights the crucial role of Cav3.2 channels in inflammation and related pain and suggests that targeting Cav3.2 channels with pharmacological agents could be an attractive and readily evaluable strategy in a clinical trial to relieve chronic inflammatory pain in affected patients.
Keywords: inflammatory pain, rheumatoid arthritis (RA), T-type calcium channels.